Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5457]

The global platform for access to childhood cancer medicines

Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA

The global platform for access to childhood cancer medicines ( Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA )

Cancer medicine shortages for children around the world

Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis...

Cancer medicine shortages for children around the world ( Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA )

OncoAlert and ecancer round up: SABCS 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer round up: SABCS 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with...

Prof Meral Beksac and Prof Roman Hájek

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma ( Prof Meral Beksac and Prof Roman Hájek )

Silver linings: a qualitative study of desirable changes to cancer care during...

Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe...

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic ( Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand )

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first...

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for...

Dr Michael Bishop - University of Chicago, Chicago, USA

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL ( Dr Michael Bishop - University of Chicago, Chicago, USA )

Integrated genomic analysis identifies UBTF tandem duplications as a subtype...

Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA

Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML ( Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA )

Asciminib found to be safe and effective for heavily pretreated patients with...

Dr Michael Mauro - Memorial Sloan Kettering Cancer Center, New York, USA

Asciminib found to be safe and effective for heavily pretreated patients with chronic myeloid leukaemia in chronic phase ( Dr Michael Mauro - Memorial Sloan Kettering Cancer Center, New York, USA )

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first...

Prof Andrew Wei - Monash University, Melbourne, Australia

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first remission after intensive chemo ( Prof Andrew Wei - Monash University, Melbourne, Australia )

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL

Dr Ibrahim Aldoss - City of Hope, Duarte, USA

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL ( Dr Ibrahim Aldoss - City of Hope, Duarte, USA )

Azacitidine, venetoclax and gilteritinib for FLT3-mutated AML

Prof Nicholas Short - The University of Texas MD Anderson Cancer Center...

Azacitidine, venetoclax and gilteritinib for FLT3-mutated AML ( Prof Nicholas Short - The University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer